semaglutide by novo nordisk Sinks on Disappointing Trial Results for Next Gen Weight Loss Drug Novo Nordisk withdraws FDA application

Data from clinical studies In an observational study involving 20 diabetic subjects receiving background metformin therapy, exenatide treatment over 16 weeks resulted in improved flow-mediated vasodilation of the brachial artery following 5 min of forearm ischemia, as assessed by ultrasound echocardiography, compared to patients treated with glimepiride [85]

S.GeorgiouN

Nausea and vomiting are frequent when starting, and diarrhea, abdominal pain, or constipation can occur as your system adjusts

However, these formulations work best when used under the guidance of a trusted healthcare provider and purchased from a licensed pharmacy